Not investment advice. NasdaqScan is a free, independent educational tool. Results are automated and may contain errors. Trading involves risk of loss. Read full disclaimer
DAILY CHART

NKTR daily chart – Nektar Therapeutics sideways range & retest on the daily timeframe

NASDAQ

You are looking at the daily chart. Each candle is one trading day, and every date on this page is a single trading day. For the weekly chart (one candle per week), see NKTR on the weekly chart.

On the daily chart, NKTR has been moving sideways between $33.40 and $75.67 since 30 Jan 2026.

The pattern: price breaks out below a sideways range, the pullback back into the range fails, and price comes back to retest the low. Traders also call this a spring. On this page NasdaqScan flags the daily candle (the trading day) that makes the retest.

DAILYDaily chart: each candle is one trading day.

Daily chart. The purple band is the sideways range of the latest signal; green triangles mark the trading days NasdaqScan detected a retest.

Sideways ranges on the daily chart

RangeStartedEndedHow it endedRetest signals (trading day)
30 Jan 2026Open——
20 Aug 202523 Feb 2026 (187 days)Broke above the range at $75.67—
7 Jan 20256 Oct 2025 (272 days)Broke above the range at $62.95—
13 May 202412 Feb 2025 (275 days)Broke below the range at $9.75—
3 Mar 202331 Oct 2023 (242 days)Broke below the range at $6.60—
25 Aug 202225 Jan 2023 (153 days)Broke below the range at $32.85—
1 Mar 202229 Sept 2022 (212 days)Broke below the range at $44.4014 Jun 2022 (BO accepted)
20 Jan 202215 Mar 2022 (54 days)Broke below the range at $58.20—

Retest signals on the daily chart

  • 14 Jun 2022 (daily candle): retest of the low after a breakout below a sideways range, 105 days after the range began (BO accepted)

Other stocks with a recent daily-chart retest

NKTR on the weekly chart →
All daily-chart retest signals →
All NASDAQ stocks with daily retest patterns →
All NASDAQ stocks with weekly retest patterns →

Past patterns don't predict future price moves. This page shows what an automated algorithm detected and is not financial advice. Read the disclaimer.